4.7 Article

Inhibitory effects of recombinant porcine interferon-α on porcine transmissible gastroenteritis virus infections in TGEV-seronegative piglets

期刊

VETERINARY MICROBIOLOGY
卷 252, 期 -, 页码 -

出版社

ELSEVIER
DOI: 10.1016/j.vetmic.2020.108930

关键词

Porcine interferon-alpha (rPoIFN-alpha); Porcine transmissible gastroenteritis virus (TGEV); Pathology; RT-qPCR; Virus challenge

资金

  1. National Key R&D Program of China [2017YFD0501000]
  2. Natural Science Foundation of Anhui Province [1808085MC75]
  3. Wuhu Science and Technology Plan Project [2019yf44]
  4. Scientific research activities of postdoctoral researchers in Anhui [20178194]

向作者/读者索取更多资源

The research found that the dose of rPoIFN-alpha affects pigs' resistance to TGEV, with a higher dose (2 x 10(7)IU/pig) providing full protection, a moderate dose (2 x 10(6)IU/pig) offering partial protection, and a low dose (2 x 10(5)IU/pig) unable to adapt to the challenge. However, rPoIFN-alpha can delay the onset of clinical symptoms in pigs.
Our previous research obtained purified recombinant porcine interferon-alpha (rPoIFN-alpha) containing thioredoxin (Trx) fusion tag in E. coli Rosetta (DE3). Here, we evaluate the efficacy of this rPoIFN-alpha to prevent piglets from the infection of the transmissible gastroenteritis virus (TGEV) attack. In this experiment, twenty-five TGEV-seronegative piglets were randomly divided into five groups. Group 1 was positive control and only challenged with TGEV; Pigs in groups 2-4 were pretreated with 2 x 10(7)IU/pig, 2 x 10(6)IU/pig, and 2 x 10(5)IU/pig rPoIFN-alpha before TGEV challenge. The fifth group is a negative control group. The animals of this group are pretreated only with Trx protein-containing PBS solution without TGEV challenge. After 48 h of rPoIFN-alpha pretreatment, the pigs in groups 1-4 were challenged by TGEV, and the pigs in group 5 were administered with PBS. The surveillance results show that Pigs pre-treated with 2 x 10 (7) IU/pig rPoIFN-alpha are fully aligned with the violent TGEV attack. Pigs pretreated with 2 x 10 (6) IU/pig rPoIFN-a are partially aligned with the violent TGEV attack. Though piglets pretreated with 2 x 10(6) IU/pig or 2 x 10(5)IU/pig rPoIFN-alpha cannot be adapted to the challenge of TGEV. However, the use of this dose of rPoIFN-alpha could put off the clinical signs of pigs than the positive control group of the above. These results indicate that rPoIFN-alpha can protect pigs from the infection of potential TGEV or delay the appearance of clinical symptoms, and its effect is dose-dependent.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据